HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Kerstin Albus Selected Research
Kerstin Albus Research Topics
Disease
5
Neoplasms (Cancer)
10/2016 - 11/2012
4
Lung Neoplasms (Lung Cancer)
11/2015 - 11/2012
1
COVID-19
01/2022
1
Communicable Diseases (Infectious Diseases)
01/2022
1
Infections
01/2021
1
Insulin Resistance
01/2021
1
Adenocarcinoma of Lung
10/2016
1
Small Cell Carcinoma
02/2016
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2015
1
Type 1 Diabetes Mellitus (Autoimmune Diabetes)
05/2011
1
Autoimmune Diseases (Autoimmune Disease)
09/2008
Drug/Important Bio-Agent (IBA)
2
Insulin (Novolin)
FDA Link
01/2021 - 05/2011
2
Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
IBA
02/2014 - 11/2012
1
Vaccines
IBA
01/2022
1
Glucagon-Like Peptide 1 (GLP 1)
IBA
01/2021
1
Glucose (Dextrose)
FDA Link
Generic
01/2021
1
rociletinib
IBA
10/2016
1
osimertinib
IBA
10/2016
1
Phosphotransferases (Kinase)
IBA
11/2015
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
11/2015
1
DNA (Deoxyribonucleic Acid)
IBA
07/2015
1
Biological Products
IBA
01/2015
1
Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)
IBA
02/2014
1
Ligands
IBA
02/2014
1
Insulins
IBA
05/2011
1
Short-Acting Insulin
IBA
05/2011
1
Insulin Lispro (Humalog)
FDA Link
05/2011
1
Complement Receptors (Complement Receptor)
IBA
09/2008
Therapy/Procedure
5
Therapeutics
10/2016 - 11/2012
1
Critical Care (Surgical Intensive Care)
01/2021
1
Aftercare (After-Treatment)
10/2016
1
Genomic Medicine
07/2015